Identification of defects in the transcriptional program during lineage-specific in vitro differentiation of CD34+ cells selected from patients with both low- and high-risk myelodysplastic syndrome
To access this article, please choose from the options below
PII: S0301-472X(10)00205-5
doi:10.1016/j.exphem.2010.04.018
© 2010 ISEH - Society for Hematology and Stem Cells. Published by Elsevier Inc. All rights reserved.
